{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:56:33Z","timestamp":1791849393566,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1136\/ard.2009.117341","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T21:30:22Z","timestamp":1272317422000},"page":"1636-1642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"title":["Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?"],"prefix":"10.1016","volume":"69","author":[{"given":"Benazir","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Keen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Goeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmin","family":"Nizam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M A","family":"Hensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Churchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G","family":"Conaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Ponchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2009.117341_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/rheumatology\/kem257","article-title":"Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis","volume":"47","author":"Emery","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.117341_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117341_bib3","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117341_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.20712","volume":"52","author":"Quinn","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117341_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jbspin.2008.11.009","article-title":"Effect of discontinuing TNFalpha antagonist therapy in patients with remission of rheumatoid arthritis","volume":"76","author":"Brocq","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1136\/ard.2009.117341_bib6","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.22190","article-title":"Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression","volume":"54","author":"Brown","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117341_bib7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","article-title":"Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis","volume":"43","author":"Nell","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.117341_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/rheumatology\/38.3.195","article-title":"The current status of ultrasonography in rheumatology","volume":"38","author":"Wakefield","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.117341_bib9","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1182\/blood-2002-03-0671","article-title":"Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis","volume":"100","author":"Ponchel","year":"2002","journal-title":"Blood"},{"key":"10.1136\/ard.2009.117341_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/ard.2007.073833","article-title":"Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse","volume":"67","author":"Burgoyne","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.117341_bib11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1136\/ard.2009.117341_bib12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4049\/jimmunol.142.2.471","article-title":"Organ-specific autoimmune-disease induced in mice by elimination of T-cell subsets: neonatal administration of cyclosporine-A causes autoimmune-disease","volume":"142","author":"Sakaguchi","year":"1989","journal-title":"J Immunol"},{"key":"10.1136\/ard.2009.117341_bib13","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.117341_bib14","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.117341_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/B:JOCI.0000019780.93817.82","article-title":"Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs","volume":"24","author":"Putheti","year":"2004","journal-title":"J Clin Immunol"},{"key":"10.1136\/ard.2009.117341_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117341_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/art.20711","article-title":"C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept","volume":"52","author":"Buch","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117341_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2005.044354","article-title":"EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"66","author":"Combe","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.117341_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.21655","article-title":"Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial","volume":"54","author":"van der Heijde","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117341_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3899\/jrheum.081018","article-title":"Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis","volume":"36","author":"Emery","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.117341_bib21","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/ar2591","article-title":"Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study","volume":"11","author":"Sokka","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.117341_bib22","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/art.23945","article-title":"An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis","volume":"58","author":"Brown","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117341_bib23","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/kel089","article-title":"Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood","volume":"45","author":"Lawson","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.117341_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.117341_bib25","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood.V99.5.1610","article-title":"Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect","volume":"99","author":"Papadaki","year":"2002","journal-title":"Blood"},{"key":"10.1136\/ard.2009.117341_bib26","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.4049\/jimmunol.164.4.2180","article-title":"Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy","volume":"164","author":"Sempowski","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/ard.2009.117341_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/ard.54.12.944","article-title":"Early rheumatoid arthritis: time to aim for remission","volume":"54","author":"Emery","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.117341_bib28","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","article-title":"Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin","volume":"7","author":"Raza","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.117341_bib29","first-page":"1281","article-title":"Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid-na\u00efve patients","volume":"31","author":"Singh","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.117341_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9343(01)00872-5","article-title":"Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies","volume":"111","author":"Lard","year":"2001","journal-title":"Am J Med"},{"key":"10.1136\/ard.2009.117341_bib31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.10135","article-title":"FINnish Rheumatoid Arthritis Combination therapy. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis","volume":"46","author":"M\u00f6tt\u00f6nen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.117341_bib32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/ard.2003.010298","article-title":"Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis","volume":"63","author":"van Aken","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.117341_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","article-title":"Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial","volume":"372","author":"Emery","year":"2008","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1136\/ard.2009.117341corr1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000}}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724193582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724193582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2009.117341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T09:04:15Z","timestamp":1736067855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724193582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0003496724193582"],"URL":"https:\/\/doi.org\/10.1136\/ard.2009.117341","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2009.117341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}